Anchor Investment Management, LLC Novo Nordisk A S Transaction History

Anchor Investment Management, LLC

$1.06 Trillion
Q3 2024

A detailed history of Anchor Investment Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Anchor Investment Management, LLC holds 13,447 shares of NVO stock, worth $1.15 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

13,447

Previous 13,150 2.26%

Holding current value

$1.15 Million

Previous $1.88 Billion 14.7%

% of portfolio

0.15%

Previous 0.19%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 21, 2024	BUY	$119.07 - $145.42 $35,363 - $43,189	297 Added 2.26%	13,447 $1.6 Billion
Q2 2024 Sep 20, 2024	BUY	$122.71 - $146.91 $7,362 - $8,814	60 Added 0.46%	13,150 $1.88 Billion
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $27,161 - $36,154	266 Added 2.07%	13,090 $1.68 Billion
Q4 2023 Jan 02, 2024	BUY	$87.78 - $105.45 $1.13 Million - $1.35 Million	12,824 New	12,824 $1.33 Billion
Q3 2023 Jan 02, 2024	BUY	$90.94 - $199.54 $610,389 - $1.34 Million	6,712 Added 100.0%	13,424 $1.22 Billion
Q2 2023 Jan 02, 2024	BUY	$155.98 - $172.65 $31,195 - $34,530	200 Added 3.07%	6,712 $1.09 Billion
Q1 2023 Jan 02, 2024	SELL	$132.34 - $159.14 $52,936 - $63,655	-400 Reduced 5.79%	6,512 $1.04 Billion
Q4 2022 Jan 02, 2024	SELL	$102.55 - $135.33 $606,275 - $800,070	-5,912 Reduced 46.1%	6,912 $935 Million
Q3 2022 Jan 02, 2024	SELL	$95.28 - $116.93 $563,295 - $691,290	-5,912 Reduced 46.1%	6,912 $689 Million
Q1 2022 Jan 02, 2024	SELL	$93.1 - $112.54 $34,912 - $42,202	-375 Reduced 4.82%	7,412 $823 Million
Q3 2021 Jan 02, 2024	SELL	$84.42 - $106.62 $425,223 - $537,044	-5,037 Reduced 39.28%	7,787 $748 Million
Q4 2020 Jan 02, 2024	SELL	$63.89 - $73.8 $47,917 - $55,350	-750 Reduced 8.79%	7,787 $544 Million
Q3 2020 Jan 02, 2024	SELL	$63.69 - $70.22 $273,039 - $301,033	-4,287 Reduced 33.43%	8,537 $593 Million
Q4 2019 Jan 02, 2024	SELL	$49.86 - $58.26 $19,944 - $23,304	-400 Reduced 4.48%	8,537 $494 Million
Q3 2019 Jan 02, 2024	SELL	$47.54 - $53.43 $184,787 - $207,682	-3,887 Reduced 30.31%	8,937 $462 Million
Q2 2019 Jan 02, 2024	SELL	$46.79 - $52.47 $46,790 - $52,470	-1,000 Reduced 10.06%	8,937 $456 Million
Q4 2018 Jan 02, 2024	SELL	$41.54 - $47.25 $162,006 - $184,275	-3,900 Reduced 28.19%	9,937 $458 Million
Q3 2018 Jan 02, 2024	BUY	$46.76 - $51.24 $47,367 - $51,906	1,013 Added 7.9%	13,837 $652 Million
Q2 2018 Jan 03, 2024	BUY	$44.29 - $50.42 $56,824 - $64,688	1,283 Added 10.0%	14,107 $651 Million
Q4 2017 Jan 03, 2024	SELL	$47.53 - $53.73 $46,817 - $52,924	-985 Reduced 6.53%	14,107 $757 Million
Q3 2017 Jan 03, 2024	BUY	$41.15 - $49.22 $43,907 - $52,517	1,067 Added 7.61%	15,092 $727 Million
Q2 2017 Jan 03, 2024	BUY	N/A	1,201 Added 9.37%	14,025 $602 Million
Q1 2017 Jan 03, 2024	BUY	N/A	2,425 Added 23.04%	12,950 $444 Million
Q4 2016 Jan 03, 2024	BUY	N/A	2,900 Added 38.03%	10,525 $377 Million
Q2 2016 Jan 03, 2024	SELL	N/A	-5,199 Reduced 40.54%	7,625 $410 Million
Q1 2016 Jan 03, 2024	SELL	N/A	-5,699	7,125 $386 Million

Others Institutions Holding NVO

# of Institutions

1,892

Shares Held

318M

Call Options Held

5.49M

Put Options Held

7.77M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Investment Management, LLC with notifications on news.

Account

Anchor Investment Management, LLC Novo Nordisk A S Transaction History